3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
4
Neoplasms
4
Colonic Neoplasms
4
Leukemia, Myeloid, Acute
3
Hodgkin Disease
3
Gallbladder Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Sarcoma
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
HIV Infections
2
Congenital Abnormalities
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Bile Duct Neoplasms
2
Anus Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Dysplasia
1
Interventions
Doxorubicin
15
Zidovudine
12
Vincristine
11
Bleomycin
10
Interferon alpha-2
6
Cyclophosphamide
5
tecogalan
4
sargramostim
4
Methotrexate
4
Liposomes
4
Leucovorin
4
Filgrastim
4
Etoposide
4
Dexamethasone
4
Cytarabine
4
Fluorouracil
3
interferon alfa-n1
2
Valganciclovir
2
Tumor Necrosis Factor-alpha
2
Thalidomide
2
Rituximab
2
Ritonavir
2
Nivolumab
2
Mitoxantrone
2
Isotretinoin
2
Interleukin-2
2
Electrocoagulation
2
Didanosine
2
Allopurinol
2
ziconotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Acquired Immunodeficiency Syndrome
×
Watchful Waiting
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts